Boston Sci Q2 Revenue Up 23%

Boston Scientific (BSX -0.32%), a leading medical device maker known for its heart and surgical products, released second-quarter results on July 23, 2025. Revenue reached $5.06 billion for Q2 2025, beating analyst estimates of $4.89 billion. Adjusted EPS finished at $0.75 for Q2 2025 compared to a consensus estimate of $0.73. Driven by high performance in Cardiovascular devices, the period marked another quarter of strong execution, but management noted some lag in organic net sales growth in its MedSurg a ...